Clinical Evidence for TMS Therapy
Scientific Research Supporting TMS Therapy
Transcranial Magnetic Stimulation (TMS) therapy has been extensively studied and clinically tested for its effectiveness in treating migraines. Multiple research studies confirm its ability to reduce migraine frequency, severity, and reliance on medication.
Key Findings from Clinical Studies
- Reduced Migraine Frequency: Studies show that regular use of TMS can lead to fewer migraine episodes per month.
- Decreased Pain Intensity: Patients report less severe headaches when using TMS therapy.
- Lower Medication Dependence: Many participants in clinical trials reduced their use of painkillers and migraine medications.
- High Patient Satisfaction: Over 75% of TMS users report noticeable improvement in their migraine management.
Clinical Trials & Published Research
Numerous peer-reviewed studies have evaluated the safety and efficacy of TMS therapy for migraine relief. Below are some key studies:
- Journal of Neurology (2021): A randomized controlled trial demonstrating significant migraine reduction in TMS users.
- Headache Journal (2020): A meta-analysis of clinical trials confirming the long-term benefits of TMS therapy.
- FDA Clearance Data (2019): The approval process and supporting research behind the use of TMS for migraine treatment.
For more details on specific studies, visit our FDA-Cleared Devices page.
Frequently Asked Questions
Is there scientific proof that TMS therapy works?
Yes, multiple clinical studies and FDA-reviewed research support the effectiveness of TMS for migraine relief.
How long does it take to see results from TMS therapy?
Some users experience relief within minutes, while long-term benefits are seen with consistent use over weeks.
Has TMS been tested in real-world clinical settings?
Yes, TMS has been tested in hospitals, headache clinics, and research institutions worldwide.
Can I access published research on TMS?
Yes, visit leading medical journals or our Clinical Evidence page for study summaries.